No Data
BriaCell Gains After Update on Late-stage Trial for Lead Asset
BriaCell Provides Phase 3 Clinical Engagement Update in Metastatic Breast Cancer Pivotal Study
Express News | HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $15 Price Target
Express News | Briacell Therapeutics Announces $5 Million Offering
BriaCell Therapeutics Announces $5 Million Offering
BriaCell Dips Despite Promising Mid-stage Data for Breast Cancer Therapy